Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
Conduit regains compliance with Bid Price and Equity RequirementsCDT will continue to be listed and traded on The Nasdaq Stock...
Clinical Trial
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and...
Red Light Holland’s FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company’s Raw Psilocybin Truffles
Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the...
Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101
Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment...
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery...
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team...
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the...
NeurAxis Announces $5.0 Million Registered Direct Offering
CARMEL, Ind., May 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
VALUE Phase III trial of EscharEx® in venous leg ulcers advancing as planned NexoBrid® manufacturing expansion on track; full operational...
GenVivo Highlights Non-Integrating Retroviral Vector Technology with Persistent Payload Expression at the 2025 Retroviruses Meeting
Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene...
NervGen Pharma to Present Topline Data for NVG-291 Phase 1b/2a Chronic Cohort Study at the American Spinal Injury Association Annual Scientific Meeting
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company...
SGS Announces ISO 17025 Accreditation of Canadian Pharmaceutical Lab Now Offering Extractables and Leachables Testing
MISSISSAUGA, ON, May 20, 2025 /PRNewswire/ - SGS, the world's leading testing, inspection, and certification company, has gained ISO 17025 accreditation...
Federal Action Needed to Close Mental Health Care Gaps Despite 10-Fold Growth in Proven Care Model
The COMPLETE Care Act could drive further expansion of the Collaborative Care Model WASHINGTON, May 20, 2025 /PRNewswire/ -- A...
myTomorrows Surpasses 15,000 Patient Matches through AI-Powered Platform and Personalized Services
On International Clinical Trials Day, myTomorrows, whose AI-powered platform connects patients with pre-approval treatments, celebrates the milestone of successfully matching...
New Domino Capabilities Fuel Life Sciences Innovation Amid Surging Industry Demand
With growing adoption across top-10 pharma, Domino's new capabilities reduce friction and put analytics insights directly in the hands of...
RealTime eClinical Solutions Honors Research Organizations as “Guiding Stars of Clinical Trials” in Celebration of Clinical Trials Day 2025
SAN ANTONIO, May 20, 2025 /PRNewswire/ -- In celebration of Clinical Trials Day 2025, RealTime eClinical Solutions, a leading provider...
Trial Library Works with Texas Oncology to Enhance Patient Clinical Trial Navigation
SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Trial Library, a technology company focused on equitable access to oncology clinical trials,...
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 20, 2025 /PRNewswire/ -- Equity Insider...
New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection
Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures. REDWOOD CITY, Calif., May 20, 2025...